Study objectives: We analyzed data from a community-based cancer database over a 26-year period in order to characterize clinicopathologic differences between black and white patients with lung cancer, and to identify relevant temporal trends in incidence and survival. Design, setting, and patients: Data on demographics, stage, histology, and survival were obtained on all black and white patients with primary bronchogenic carcinoma registered in the community-based metropolitan Detroit Surveillance, Epidemiology, and End Results database from 1973 to 1998. Results: Of 48,318 eligible patients, 23 % were black. Lung cancer incidence rates decreased for men of both races from 1985 to 1998, with a greater decline occurring in black men (p <...
Objective. Does ethnicity have an impact on the treatment outcome when controlling for stage of canc...
ObjectiveThe examination of lung cancer by histology type is important for monitoring population tre...
Purpose:Conditional survival (CS) is an accurate estimate of survival probability for patients who h...
BACKGROUND:Lung cancer (LC) incidence in the United States (US) continues to decrease but with signi...
<div><p>Background</p><p>Lung cancer (LC) incidence in the United States (US) continues to decrease ...
ObjectiveExamination of factors that may contribute to racial disparity among those with lung cancer...
© 2018 The American Association for Thoracic Surgery Objective: Although the incidence of lung cance...
Although race, in and of itself, is not a relevant biologic variable, racial differences in disease ...
Introduction: Social determinants of health are particularly important in lung cancer epidemiology. ...
Background: The objective of the study was to estimate the racial disparities in the quality of care...
Background: It remains unknown how race-based differences in cancer outcomes have changed with time....
Certain population groups in the United States carry a disproportionate burden of cancer. This work ...
Lung cancer remains the most common cause of cancer mortality in both Rhode Island and the United St...
BackgroundWe analyzed the survival trends for patients with metastatic lung cancer in California.Mat...
The purpose of this study is to compare the racial differences in treatment and overall survival (OS...
Objective. Does ethnicity have an impact on the treatment outcome when controlling for stage of canc...
ObjectiveThe examination of lung cancer by histology type is important for monitoring population tre...
Purpose:Conditional survival (CS) is an accurate estimate of survival probability for patients who h...
BACKGROUND:Lung cancer (LC) incidence in the United States (US) continues to decrease but with signi...
<div><p>Background</p><p>Lung cancer (LC) incidence in the United States (US) continues to decrease ...
ObjectiveExamination of factors that may contribute to racial disparity among those with lung cancer...
© 2018 The American Association for Thoracic Surgery Objective: Although the incidence of lung cance...
Although race, in and of itself, is not a relevant biologic variable, racial differences in disease ...
Introduction: Social determinants of health are particularly important in lung cancer epidemiology. ...
Background: The objective of the study was to estimate the racial disparities in the quality of care...
Background: It remains unknown how race-based differences in cancer outcomes have changed with time....
Certain population groups in the United States carry a disproportionate burden of cancer. This work ...
Lung cancer remains the most common cause of cancer mortality in both Rhode Island and the United St...
BackgroundWe analyzed the survival trends for patients with metastatic lung cancer in California.Mat...
The purpose of this study is to compare the racial differences in treatment and overall survival (OS...
Objective. Does ethnicity have an impact on the treatment outcome when controlling for stage of canc...
ObjectiveThe examination of lung cancer by histology type is important for monitoring population tre...
Purpose:Conditional survival (CS) is an accurate estimate of survival probability for patients who h...